Life Science News

Cloud DX (TSX.V:CDX), a leading Canadian provider of virtual care and remote patient monitoring solutions, announced its support and intention to participate in offering its award-winning remote patient monitoring platform, the Cloud DX Connected Health Kit to provincial and territory healthcare providers as part of the Government of Canada's newly signed bilateral agreement to enhance provincial virtual care services, including $46M in funding flowing to the Province of Ontario. Remote patient monitoring is identified as one of five priority areas for immediate action

"With the COVID-19 third wave upon us, there is heightened urgency to act swiftly and decisively to bring virtual care services to every Canadian. Now is the time for the private and public sector to come together like never before to ensure people across this country have continued access to the health care services they need virtually during this time of great uncertainty. With a fully commercialized, Health Canada compliant, made-in-Canada solution at the ready, Cloud DX is standing by to bring our easy to use, easy to adopt remote patient monitoring solution to healthcare providers across this country. Connected Health is already in use from coast-to-coast, including for COVID-19 patients, and our message to hospital administrators, doctors, and other care providers is this: we are ready to assist and can have you and your patients up and running very quickly," says Robert Kaul, CEO of Cloud DX

Cloud DX

Accelerating virtual healthcare's future, Cloud DX is making healthcare better for everyone. The company's Connected Health remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable ageing in place and deliver hospital-quality post-surgical care. Providers partnering with Cloud DX achieve better healthcare and patient outcomes, reduce the need for hospitalization/re-hospitalization and reduce the costs of healthcare delivery through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist and one of Canada's 10 most prominent Telehealth providers.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Social Links

Twitter: https://twitter.com/CloudDX
Facebook https://www.facebook.com/clouddxinc/
LinkedIn https://www.linkedin.com/company/cloud-dx/

For media inquiries please contact:

Ellyn Winters-Robinson
Ignition Communications (PR for Cloud DX)
519-574-2196
ellyn@ignition.ca

For investor inquiries please contact:

Jay Bedard
Cloud DX Investor Relations
647-881-8418
jay.bedard@CloudDX.com

Cloud DX Corporate Contact

Robert Kaul
CEO
1-646-706-1807
Robert.kaul@clouddx.com

SOURCE: Cloud DX Inc.



View source version on accesswire.com:
https://www.accesswire.com/641829/Cloud-DX-Announces-Intention-to-Participate-in-the-Government-of-Canadas-Expansion-of-Virtual-Care

News Provided by ACCESSWIRE via QuoteMedia

Oculus VisionTech Reports 2022 Annual General Meeting Results

Oculus VisionTech Reports 2022 Annual General Meeting Results

Oculus VisionTech Inc. (TSXV: OVT) (OTCQB: OVTZ) (FSE: USF1) is pleased to announce the results of its 2022 Annual General Meeting ("AGM"). The AGM was held on September 15, 2022 in Vancouver, British Columbia. All resolutions put forward at the meeting were approved by shareholders. A total of 60,059,026 common shares (65.69% of the 91,422,569 issued and outstanding shares of the Company entitled to vote as of the July 19, 2022 record date for the AGM) were present in person or by proxy, constituted a quorum for the transaction of business and were voted at the AGM. The agenda items submitted at the AGM were passed as described below. Percentages indicated below reflect the percentage of the total number of shares voted at the AGM with respect to that agenda item.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Applied UV's Airocide® and Lumicide Address CDC's Recommendation for Handling Environments Contaminated by Monkeypox

Applied UV's Airocide® and Lumicide Address CDC's Recommendation for Handling Environments Contaminated by Monkeypox

Applied UV, Inc. (NasdaqCM: AUVI ) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically affirms that its pathogen killing technology SteriLumen's Airocide® and Lumicide are highly effective, differentiating solutions for addressing recent recommendations from the Centers for Disease Control (CDC) for cleaning and disinfecting settings that may be contaminated with Monkeypox and other orthopoxviruses.

In a recent publication, available here , the CDC provided considerations for disinfecting settings that may be contaminated with Monkeypox virus and highlighted the virus' sensitive to UV light, disinfectants and household cleaners in a tweet available here .

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
dynaCERT to Exhibit at IAA Transportation 2022, the World's Largest Platform for Transport and Logistics, to be held in Hanover, Germany from September 20th to 25th

dynaCERT to Exhibit at IAA Transportation 2022, the World's Largest Platform for Transport and Logistics, to be held in Hanover, Germany from September 20th to 25th

dynaCERT Inc. (TSX: DYA) (OTCQX: DYFSF) (FRA: DMJ) (" dynaCERT " or the "Company") is pleased to announce its participation exhibiting at the IAA Transportation Trade Show 2022 being held from September 20 th to 25 th in Hanover, Germany. IAA Transportation, under the motto "People and Goods on the Move", is the world's largest platform for transport and logistics and will host over 2,000 exhibitors from across the world. More than 250,000 attendees are expected during the six days of the show.

At the IAA Transportation Trade Show 2022 dynaCERT will be exhibiting its proprietary HydraGEN™ Technology designed to reduce fuel consumption and pollutants such as GHG's currently available globally for small, medium and large diesel vehicles and generators.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
BriaCell Partners with Caris Life Sciences® to Expand Patient Outreach and Molecular Profiling

BriaCell Partners with Caris Life Sciences® to Expand Patient Outreach and Molecular Profiling

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company") a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer, announces that it has signed an agreement with Caris Life Sciences ® (Caris), a leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare.

"Our goal is to develop immunotherapies that are personalized for each patient, and Caris' extensive library of clinical data, cutting-edge biomarker technology, and expertise will be invaluable in achieving our objectives," stated Dr. Giuseppe Del Priore, BriaCell's Chief Medical Officer. "We expect Caris' unique platform to help us identify patients who do not respond to existing treatments and are more likely to benefit from our immunotherapy treatments."

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Bloom Health Partners Announces New Location in Hawaii

Bloom Health Partners Announces New Location in Hawaii

New Bloom lab will support operations in the Honolulu area and surrounding region

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of operational health and health technology, announces the opening of a new location in in the Honolulu area.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
GOAT Enters Into Letter of Intent to Acquire Canadian License for Direct Lithium Extraction Technology

GOAT Enters Into Letter of Intent to Acquire Canadian License for Direct Lithium Extraction Technology

GOAT Industries Ltd. (the " Company " or " GOAT ") (CSE: GOAT), is pleased to announce the Company has entered into a non-binding Letter of Intent (the " LOI ") dated September 14, 2022 with 1000288601 Ontario Inc. (" Ontario Co ").

The LOI contemplates a proposed transaction (the " Proposed Transaction "), whereby GOAT would acquire all issued and outstanding securities of Ontario Co by way of a share exchange agreement (the " Share Exchange "). Ontario Co is in the process of acquiring the Canadian license for a Direct Lithium Extraction technology (the " DLE Technology ") developed by private industry, as well as University researchers based out of Australia.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×